Versant Capital Management Inc Has $506,000 Stake in Genpact Limited (NYSE:G)

Versant Capital Management Inc grew its position in shares of Genpact Limited (NYSE:G - Free Report) by 215.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,037 shares of the business services provider's stock after acquiring an additional 6,859 shares during the quarter. Versant Capital Management Inc's holdings in Genpact were worth $506,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of G. SG Americas Securities LLC purchased a new stake in shares of Genpact in the fourth quarter worth about $238,000. Blue Trust Inc. boosted its holdings in Genpact by 8.7% in the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock worth $217,000 after acquiring an additional 441 shares during the period. KBC Group NV acquired a new stake in Genpact in the fourth quarter valued at approximately $298,000. Caprock Group LLC grew its position in Genpact by 22.9% in the fourth quarter. Caprock Group LLC now owns 11,938 shares of the business services provider's stock valued at $513,000 after acquiring an additional 2,222 shares in the last quarter. Finally, Sylvest Advisors LLC purchased a new stake in shares of Genpact during the fourth quarter valued at approximately $737,000. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Genpact Trading Down 0.3%

G stock traded down $0.12 during mid-day trading on Wednesday, reaching $42.62. 384,328 shares of the stock traded hands, compared to its average volume of 1,369,411. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The company has a market cap of $7.45 billion, a P/E ratio of 15.01, a P/E/G ratio of 1.84 and a beta of 1.02. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76. The stock's fifty day moving average is $46.44 and its 200-day moving average is $47.27.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The company had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The business's quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the business earned $0.73 EPS. As a group, sell-side analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.

Insider Buying and Selling at Genpact

In other news, Director Nicholas C. Gangestad acquired 2,000 shares of the stock in a transaction dated Tuesday, May 13th. The shares were acquired at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the transaction, the director now owns 2,000 shares in the company, valued at approximately $87,940. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 3.07% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Mizuho raised their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Needham & Company LLC reduced their target price on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Robert W. Baird decreased their price target on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Finally, TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the company from $45.00 to $60.00 in a report on Friday, February 7th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $50.71.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.